Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alagebrium in Diastolic Heart Failure
NCT01913301Phase 2Terminated
- Sponsor
- Cardiovascular Clinical Sciences
- Start
- Dec 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of alagebrium in Heart failure with preserved ejection fraction (HFpEF), sponsored by Cardiovascular Clinical Sciences. Started Dec 2007; status: terminated.
02
Drugs
alagebrium
03
Conditions
Heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01913301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913301.